Who
George M. Milne Jr.
Director
Company insider
Files Form 4 as: Director, Amylyx Pharmaceuticals; Director, Aurinia Pharmaceuticals; Director, Charles River Laboratories International; Director, Mettler-Toledo International; Director, Athersys, Inc / New; Director, Medimmune Inc /de.
In numbers
- Trades disclosed
- 216
- Buys
- 7
- Sells
- 20
- Bought
- $9.2M
- Sold
- $15.6M
- Companies
- 6
- Companies where not an officer
- 6
- First trade
- 3 Nov 2005
- Last trade
- 5 Oct 2026
- Last filed
- 7 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Oct 2026filed 7 Oct 2026 | AMLX Amylyx PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $831K30,000 at $27.70 | filing |
| 4 Jun 2026filed 8 Jun 2026 | AMLX Amylyx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,372 at $0.00 | filing |
| 4 Jun 2026filed 8 Jun 2026 | AMLX Amylyx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,372 at $0.00 | filing |
| 12 Jan 2026filed 14 Jan 2026 | AMLX Amylyx PharmaceuticalsBiotechnology | SEC FORM 4 Code G | —17,780 at $0.00 | filing |
| 12 Jan 2026filed 14 Jan 2026 | AMLX Amylyx PharmaceuticalsBiotechnology | SEC FORM 4 Code G | —17,780 at $0.00 | filing |
| 5 Jun 2025filed 9 Jun 2025 | AMLX Amylyx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 24 Jan 2025filed 28 Jan 2025 | AMLX Amylyx PharmaceuticalsBiotechnology | SEC FORM 4 Code G | —27,910 at $0.00 | filing |
| 3 Sep 2024filed 5 Sep 2024 | AMLX Amylyx PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $220K100,000 at $2.20 | filing |
| 6 Jun 2024filed 7 Jun 2024 | AMLX Amylyx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 25 Jan 2024filed 29 Jan 2024 | AMLX Amylyx PharmaceuticalsBiotechnology | SEC FORM 4 Code G | —9,100 at $0.00 | filing |
| 16 Jan 2024filed 18 Jan 2024 | AMLX Amylyx PharmaceuticalsBiotechnology | SEC FORM 4 Code G | —94,350 at $0.00 | filing |
| 8 Jun 2023filed 12 Jun 2023 | AMLX Amylyx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,985 at $0.00 | filing |
| 18 May 2023filed 23 May 2023 | AUPH Aurinia Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —8,733 at $0.00 | filing |
| 18 May 2023filed 23 May 2023 | AUPH Aurinia PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —8,733 | filing |
| 16 Mar 2023filed 20 Mar 2023 | AMLX Amylyx PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $1.1M33,084 at $31.86 | filing |
| 16 Mar 2023filed 20 Mar 2023 | AMLX Amylyx PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $62K1,916 at $32.45 | filing |
| 2 Mar 2023filed 6 Mar 2023 | AUPH Aurinia PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $178K20,000 at $8.91 | filing |
| 29 Dec 2022filed 14 Feb 2023 | AMLX Amylyx PharmaceuticalsBiotechnology | SEC FORM 4 Code G | —13,800 at $0.00 | filing |
| 9 Jun 2022filed 10 Jun 2022 | AMLX Amylyx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —19,000 at $0.00 | filing |
| 18 May 2022filed 20 May 2022 | AUPH Aurinia Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,733 at $0.00 | filing |
News
Amylyx Pharmaceuticals (NASDAQ:AMLX) Price Target Raised to $39.00AMLX · dailypolitical.com · 18 Oct 2026Insider Selling: Amylyx Pharmaceuticals (NASDAQ:AMLX) Director Sells 30,000 Shares of StockAMLX · dailypolitical.com · 7 Oct 2026
0 headlines in the last 90 days name George M. Milne Jr.; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.